Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia Preliminary safety data from the trial showed the vaccine to be generally ...

GAITHERSBURG, Md. – Jan. 19, 2022 – Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today ...

Unvaxxed South Aussies holding out for the nation’s first protein-based Covid jab will not need to wait much longer. Here’s how to book for Novavax. SA Health reported almost 500 more cases on ...

On Thursday, Novavax Inc (NASDAQ:NVAX) reported fourth-quarter 2024 sales of $88.31 million, compared to $291 million a year, beating the consensus of $84.35 million. The decrease was due to lower ...

Novavax's chief commercial officer and chief business officer John Trizzino estimated the global annual revenue potential for COVID vaccines to be around $15 billion to $18 billion. (iStock / Getty ...

Novavax managed to get OKs for its COVID-19 shot in the EU, the U.K., Australia and South Korea before finally securing a much-coveted emergency use nod in the U.S. in July 2022. (Diy13/iStock/Getty ...

NEW YORK, Oct 9 (Reuters) - Vaccine maker Novavax Inc (NVAX.O), opens new tab on Monday said it has shipped millions of doses its updated COVID-19 shots to distributors after receiving the go-ahead ...